Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Pfizer Inc (PFE)

Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Unusual Options Activity Alert: 3 Stocks Setting Up for Major Profit Potential

Yesterday was not a good day for the markets. The S&P 500 lost 1.23% on Thursday, and the Dow lost 1.20%. Meanwhile, tech and Bitcoin-related stocks also had a bad day, with Qualcomm (QCOM) and Strategy (MSTR) down 8% and 17%, respectively. 

The good news for investors is that the index is up nearly 0.9% as I write this, an hour into Friday trading. The bad news is that the labor market is looking weaker by the day. The U.S. Labor Department’s latest data showed that the number of people filing for initial jobless claims increased by 22,000 in the past week to 231,000,...

Fundamentals

See More
  • Market Capitalization, $K 154,764,976
  • Shares Outstanding, K 5,685,708
  • Annual Sales, $ 63,627 M
  • Annual Income, $ 8,031 M
  • EBIT $ 18,723 M
  • EBITDA $ 25,736 M
  • 60-Month Beta 0.47
  • Price/Sales 2.41
  • Price/Cash Flow 6.47
  • Price/Book 1.62

Options Overview Details

View History
  • Implied Volatility 24.09% (-2.19%)
  • Historical Volatility 23.11%
  • IV Percentile 37%
  • IV Rank 17.21%
  • IV High 52.17% on 04/10/25
  • IV Low 18.25% on 08/18/25
  • Expected Move (DTE 5) 0.62 (2.28%)
  • Put/Call Vol Ratio 0.50
  • Today's Volume 278,975
  • Volume Avg (30-Day) 204,615
  • Put/Call OI Ratio 0.92
  • Today's Open Interest 2,770,929
  • Open Int (30-Day) 2,871,407
  • Expected Range 26.60 to 27.84

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 25 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 0.77
  • Number of Estimates 6
  • High Estimate 0.92
  • Low Estimate 0.64
  • Prior Year 0.92
  • Growth Rate Est. (year over year) -16.30%

Price Performance

See More
Period Period Low Period High Performance
1-Month
24.97 +8.99%
on 01/13/26
27.37 -0.55%
on 02/06/26
+1.79 (+7.04%)
since 01/06/26
3-Month
23.91 +13.84%
on 11/10/25
27.37 -0.55%
on 02/06/26
+2.37 (+9.54%)
since 11/06/25
52-Week
20.92 +30.15%
on 04/09/25
27.69 -1.70%
on 10/03/25
+1.39 (+5.38%)
since 02/06/25

Most Recent Stories

More News
Unusual Options Activity Alert: 3 Stocks Setting Up for Major Profit Potential

Volatility returned to markets yesterday, triggering a tech rout. Among the unusually active options on Thursday were 278 calls and puts with Vol/OI ratios of 15 or higher. Among them, these 3 stocks offer...

MSTR : 134.93 (+26.11%)
VFC : 20.34 (+1.19%)
QCOM : 137.34 (+0.76%)
ETSY : 57.82 (+6.17%)
LOGI : 91.45 (+2.86%)
NVO : 47.64 (+9.92%)
LLY : 1,058.18 (+3.66%)
PFE : 27.22 (+2.76%)
FDA Grants Priority Review for HYMPAVZI® (marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need

Submission is to expand HYMPAVZI indication to the treatment of hemophilia A or B patients 6 years and older with inhibitors, and pediatric patients (ages 6 to 11) without inhibitors ...

PFE : 27.22 (+2.76%)
Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans

Program offers significant savings on over 30 brands spanning women’s health, migraine, arthritis, rare disease and more Affirms Pfizer’s commitment...

PFE : 27.22 (+2.76%)
Pfizer Pops on Q4 Results—But This May Be the Catalyst That Matters Most

Pfizer stock jumped after a strong earnings beat and positive GLP-1 data, but investors may be overlooking a powerful oncology and AI-driven growth story.

NVDA : 185.41 (+7.87%)
LLY : 1,058.18 (+3.66%)
PFE : 27.22 (+2.76%)
More drops for technology stocks weigh on Wall Street

More drops for technology stocks weighed on Wall Street

NVDA : 185.41 (+7.87%)
GOLD : 55.32 (+9.87%)
GOOGL : 322.86 (-2.53%)
AAPL : 278.12 (+0.80%)
$SPX : 6,932.30 (+1.97%)
SMCI : 34.38 (+11.44%)
MTCH : 31.63 (+2.53%)
$IUXX : 25,075.77 (+2.15%)
PFE : 27.22 (+2.76%)
MSFT : 401.14 (+1.90%)
ADBE : 268.38 (-0.37%)
AMD : 208.44 (+8.28%)
PFE Q4 CY2025 Deep Dive: Obesity Pipeline and Cost Discipline Face Post-COVID Headwinds

PFE Q4 CY2025 Deep Dive: Obesity Pipeline and Cost Discipline Face Post-COVID Headwinds

PFE : 27.22 (+2.76%)
Tech stocks pull Wall Street lower as gold and silver prices bounce back

The U.S. stock market sank after a mixed day of trading

PYPL : 40.42 (+1.30%)
GOLD : 55.32 (+9.87%)
NVDA : 185.41 (+7.87%)
SAN : 12.71 (+3.92%)
SNDK : 597.95 (+3.77%)
$SPX : 6,932.30 (+1.97%)
BARC.LN : 478.286 (-0.53%)
WBS : 73.13 (+1.54%)
$IUXX : 25,075.77 (+2.15%)
PFE : 27.22 (+2.76%)
MSFT : 401.14 (+1.90%)
NOW : 100.74 (-1.84%)
Stocks Tumble on AI Disruption Fears

The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down -0.84%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.34%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.55%. March E-mini...

TER : 300.11 (+10.69%)
AMAT : 322.51 (+6.09%)
TRIP : 12.77 (+2.74%)
AVGO : 332.92 (+7.22%)
INTU : 443.77 (+2.04%)
HL : 22.77 (+6.85%)
CDE : 21.44 (+12.19%)
MRK : 121.93 (+1.82%)
EXPE : 236.85 (+2.40%)
FN : 503.99 (+13.84%)
TRI : 88.07 (-0.27%)
ADM : 66.33 (+1.38%)
Software Stocks Retreat and Drag the Broader Market Lower

The S&P 500 Index ($SPX ) (SPY ) today is down -0.35%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.13%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.94%. March E-mini S&P futures (ESH26...

TER : 300.11 (+10.69%)
INTU : 443.77 (+2.04%)
HL : 22.77 (+6.85%)
CDE : 21.44 (+12.19%)
MRK : 121.93 (+1.82%)
FN : 503.99 (+13.84%)
TRI : 88.07 (-0.27%)
ADM : 66.33 (+1.38%)
$IUXX : 25,075.77 (+2.15%)
PFE : 27.22 (+2.76%)
ZNH26 : 112-035s (-0.01%)
ESH26 : 6,952.75s (+1.94%)
Nasdaq Slips, Gold and Silver Stage Substantial Recovery

The S&P 500 Index ($SPX ) (SPY ) today is down -0.58%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.07%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.24%. Stock indexes are mixed today,...

TER : 300.11 (+10.69%)
AMAT : 322.51 (+6.09%)
AVGO : 332.92 (+7.22%)
HL : 22.77 (+6.85%)
CDE : 21.44 (+12.19%)
ADI : 320.45 (-0.52%)
MRK : 121.93 (+1.82%)
FN : 503.99 (+13.84%)
ADM : 66.33 (+1.38%)
TXN : 221.44 (-1.13%)
$IUXX : 25,075.77 (+2.15%)
PFE : 27.22 (+2.76%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare...

See More

Key Turning Points

3rd Resistance Point 28.40
2nd Resistance Point 27.89
1st Resistance Point 27.55
Last Price 27.22
1st Support Level 26.70
2nd Support Level 26.19
3rd Support Level 25.85

See More

52-Week High 27.69
Last Price 27.22
Fibonacci 61.8% 25.10
Fibonacci 50% 24.30
Fibonacci 38.2% 23.50
52-Week Low 20.92

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar